Dr. Ogdie: People with a lot of joint swelling tend to have an all-over pain that comes and goes, and typically, the pain improves with treatment of the psoriatic arthritis. But it can be ...

New research from the University of Bath in the UK reveals delayed diagnosis and undertreatment of psoriatic ... and treatment of PsA. Elaborating, Dr Tillett said: “With rheumatoid arthritis ...

should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous manifestations of psoriatic disease need to be considered in treatment targets.

Medically reviewed by Stella Bard, MD Psoriatic arthritis (PsA) is a chronic (long-term) condition that includes symptoms of ...

Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on treatment options and daily management.

Comorbidities, additional health conditions occurring alongside psoriatic arthritis, significantly impact treatment outcomes and quality of life. Common comorbidities include: Obesity, which ...

This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic ...

Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints ...

FRIDAY, April 18, 2025 (HealthDay News) -- It’s taking too long for people with psoriatic arthritis to be diagnosed ... damage to their joints before treatment starts, they said.

US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its monoclonal antibody Tremfya (guselkumab) for active psoriatic arthritis (PsA).

Psoriatic arthritis: Diagnosis, treatment, and steps to take. Kavanaugh A, Helliwell P, Ritchlin CT. Psoriatic arthritis and burden of disease: Patient perspectives from the population-based ...

Visible signs of psoriatic arthritis appear months and even years before a person develops the full-blown inflammatory joint ...